Work

(E1)levating COVID-19 vaccine efficiency with adenoviral E1 proteins

Year: 2022

Type: article

Abstract: Improved adenovirus-based COVID-19 vaccines provide an important tool to combat the ever-evolving virus.

Source: Science Advances

DOI: 10.1126/sciadv.ade3956

Authors: Douglas R. Green, Paul G. Thomas

Institution: St. Jude Children's Research Hospital

Language: English

Topic: SARS-CoV-2 and COVID-19 Research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $4,500

OpenAlex ID: W4293104424

FWCI:

Cites: 8

Cited by:

Related to: 10